Agency Forms Undergoing Paperwork Reduction Act Review, 15368-15369 [2013-05523]

Download as PDF 15368 Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Notices risk populations including, but not limited to, those of lower SES, Hispanic, African American and other ethnic groups. NCCDPHP is currently pursuing a key initiative to improve the efficiency and effectiveness of CDC project officers who oversee the state and territorial oral health programs. An electronic management information system (MIS) to support program management, consulting and evaluation has been developed in support of the cooperative agreement. The MIS provides a central repository of information, such as the plans of the state or territorial oral health programs (their goals, objectives, performance milestones and indicators), as well as state and territorial oral health performance activities including programmatic and financial information. State oral health programs have used the MIS to submit their required semi-annual reports to CDC (CDC Oral Health Management Information System, OMB No. 0920– 0739, 5/31/2013). The last report under the current FOA is due on October 30, 2013. CDC is requesting OMB approval to extend clearance for the MIS until December 31, 2013. Information will be reported to CDC once during this period. The extension will allow to CDC to receive final reports from the state oral health programs and to provide any technical assistance or follow-up support that may be needed to produce accurate final reports. There is no change to the estimated burden per response, which is 11 hours. All information will be collected electronically. There are no costs to respondents other than their time. The total estimated annualized burden hours are 220. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) State Oral Health Programs ............................................................................ 20 1 11 220 Dated: February 28, 2013. Ron A. Otten, Director, Office of Scientific Integrity (OSI), Office of the Associate Director for Science (OADS), Office of the Director, Centers for Disease Control and Prevention. Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. [FR Doc. 2013–05518 Filed 3–8–13; 8:45 am] National Disease Surveillance Program (OMB No. 0920–0009 Expiration 4/30/2013)—Revision— National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention, (CDC). Proposed Project BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Background and Brief Description [30Day-13–0009] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call (404) 639–7570 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Formal surveillance of 16 separate reportable diseases has been ongoing to meet the public demand and scientific interest in accurate, consistent, epidemiologic data. These ongoing disease reports include: CreutzfeldtJakob Disease (CJD), Cyclosporiasis, Dengue, Hantavirus, Kawasaki Syndrome, Legionellosis, Lyme disease, Malaria, Plague, Q Fever, Reye Syndrome, Tickborne Rickettsial Disease, Trichinosis, Tularemia, Typhoid Fever, and Viral Hepatitis. Case report forms from state and territorial health departments enable CDC to collect demographic, clinical, and laboratory characteristics of cases of these diseases. We are requesting changes to the Legionellois form that will allow CDC to better detect potential clusters and outbreaks of Legionnaires’ disease and to monitor changing epidemiological trends by collecting a greater level of detail for each legionellosis case. The burden to the respondents should be minimally affected by these proposed changes. The purpose of the proposed study is to direct epidemiologic investigations, identify and monitor trends in reemerging infectious diseases or emerging modes of transmission, to search for possible causes or sources of the diseases, and develop guidelines for prevention and treatment. The data collected will also be used to recommend target areas most in need of vaccinations for selected diseases and to determine development of drug resistance. Because of the distinct nature of each of the diseases, the number of cases reported annually is different for each. There is no cost to respondents other than their time. The total burden requested is 11,447 hours. mstockstill on DSK4VPTVN1PROD with NOTICES ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Epidemiologist Epidemiologist Epidemiologist Epidemiologist Epidemiologist Epidemiologist VerDate Mar<15>2010 ................................................. ................................................. ................................................. ................................................. ................................................. ................................................. 16:19 Mar 08, 2013 Number of respondents Form name Jkt 229001 CJD ................................................................ Cyclosporiasis ................................................ Dengue ........................................................... Hantavirus ...................................................... Kawasaki Syndrome ...................................... Legionellosis ................................................... PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\11MRN1.SGM Number of responses per respondent 20 55 55 46 55 23 11MRN1 2 10 182 3 8 12 Average burden per response (in hrs) 20/60 15/60 15/60 20/60 15/60 20/60 15369 Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Type of respondent Epidemiologist Epidemiologist Epidemiologist Epidemiologist Epidemiologist Epidemiologist Epidemiologist Epidemiologist Epidemiologist Epidemiologist ................................................. ................................................. ................................................. ................................................. ................................................. ................................................. ................................................. ................................................. ................................................. ................................................. Dated: February 28, 2013. Ron A. Otten, Director, Office of Scientific Integrity (OSI), Office of the Associate Director for Science (OADS), Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2013–05523 Filed 3–8–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK4VPTVN1PROD with NOTICES Board of Scientific Counselors, Office of Public Health Preparedness and Response (BSC, OPHPR) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: April 2, 2013 9:30 a.m.–3:00 p.m. (BSC, OPHPR meeting) April 3, 2013 8:30 a.m.–3:30 p.m. (Joint meeting of the BSC, OPHPR and the National Biodefense Science Board [NBSB]) Place: CDC, 1600 Clifton Road NE., Roybal Campus, Building 19, Room 256 Atlanta, Georgia 30329. Status: Open to the public limited only by the space available. The meeting room will accommodate up to 30 people. Public participants should preregister for the meeting as described in Additional Information for Public Participants. Purpose: This Board is charged with providing advice and guidance to the Secretary, Department of Health and Human Services (HHS), the Assistant Secretary for Health (ASH), the Director, Centers for Disease Control and Prevention (CDC), and the Director, Office of Public Health Preparedness and Response (OPHPR), concerning VerDate Mar<15>2010 16:19 Mar 08, 2013 Number of respondents Form name Jkt 229001 Lyme Disease ................................................ Malaria ............................................................ Plague ............................................................ Q Fever .......................................................... Reye Syndrome ............................................. Tick-borne Rickettsia ...................................... Trichinosis ...................................................... Tularemia ....................................................... Typhoid Fever ................................................ Viral hepatitis .................................................. strategies and goals for the programs and research within OPHPR, monitoring the overall strategic direction and focus of the OPHPR Divisions and Offices, and administration and oversight of peer review of OPHPR scientific programs. For additional information about the Board, please visit: http:// www.cdc.gov/phpr/science/ counselors.htm. Matters To Be Discussed: Agenda items for this meeting include: (1) Briefings and BSC deliberation on the following topics: Public Health Preparedness and Response Policy Updates; improving critical information sharing across CDC; biosecurity risk evaluation software; measuring operational readiness; (2) BSC liaison representative updates to the Board highlighting organizational activities relevant to the OPHPR mission. Day 2 of the meeting will include a joint Federal Advisory Committee briefing with NBSB, deliberation and vote on the recommendations and report written by the joint BSC, OPHPR–NBSB Strategic National Stockpile ad hoc working group. [The National Biodefense Science Board (NBSB) was created under the authority of the Pandemic and All-Hazards Preparedness Act, signed into law on December 19, 2006. The Board is a FACA committee utilized by the Office of the Assistant Secretary for Preparedness and Response. The NBSB was established to provide expert advice and guidance to the Secretary of the U.S. Department of Health and Human Services (HHS) on scientific, technical, and other matters of special interest to HHS regarding activities to prevent, prepare for, and respond to adverse health effects of public health emergencies resulting from chemical, biological, nuclear, and radiological events, whether naturally occurring, accidental, or deliberate.] Agenda items are subject to change as priorities dictate. PO 00000 Frm 00029 Fmt 4703 Sfmt 9990 Number of responses per respondent 52 55 11 55 50 55 25 55 55 55 Average burden per response (in hrs) 385 20 1 1 1 18 1 2 6 200 10/60 15/60 20/60 10/60 20/60 10/60 20/60 20/60 20/60 25/60 Additional Information for Public Participants: Members of the public that wish to attend this meeting should preregister by submitting the following information by email, facsimile, or phone (see Contact Person for More Information) no later than 12:00 noon (EDT) on Monday, March 25, 2013: • Full Name, • Organizational Affiliation, • Complete Mailing Address, • Citizenship, and • Phone Number or Email Address Contact Person for More Information: Marquita Black, Office of Science and Public Health Practice Executive Assistant, Centers for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop D–44, Atlanta, Georgia 30333, Telephone: (404) 639–7325; Facsimile: (404) 639–7977; Email: OPHPR.BSC.Questions@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention, and Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–05561 Filed 3–8–13; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\11MRN1.SGM 11MRN1

Agencies

[Federal Register Volume 78, Number 47 (Monday, March 11, 2013)]
[Notices]
[Pages 15368-15369]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05523]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-13-0009]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments 
to CDC Desk Officer, Office of Management and Budget, Washington, DC 
20503 or by fax to (202) 395-5806. Written comments should be received 
within 30 days of this notice.

Proposed Project

    National Disease Surveillance Program (OMB No. 0920-0009 Expiration 
4/30/2013)--Revision--National Center for Emerging and Zoonotic 
Infectious Diseases (NCEZID), Centers for Disease Control and 
Prevention, (CDC).

Background and Brief Description

    Formal surveillance of 16 separate reportable diseases has been 
ongoing to meet the public demand and scientific interest in accurate, 
consistent, epidemiologic data. These ongoing disease reports include: 
Creutzfeldt-Jakob Disease (CJD), Cyclosporiasis, Dengue, Hantavirus, 
Kawasaki Syndrome, Legionellosis, Lyme disease, Malaria, Plague, Q 
Fever, Reye Syndrome, Tickborne Rickettsial Disease, Trichinosis, 
Tularemia, Typhoid Fever, and Viral Hepatitis. Case report forms from 
state and territorial health departments enable CDC to collect 
demographic, clinical, and laboratory characteristics of cases of these 
diseases. We are requesting changes to the Legionellois form that will 
allow CDC to better detect potential clusters and outbreaks of 
Legionnaires' disease and to monitor changing epidemiological trends by 
collecting a greater level of detail for each legionellosis case. The 
burden to the respondents should be minimally affected by these 
proposed changes.
    The purpose of the proposed study is to direct epidemiologic 
investigations, identify and monitor trends in reemerging infectious 
diseases or emerging modes of transmission, to search for possible 
causes or sources of the diseases, and develop guidelines for 
prevention and treatment. The data collected will also be used to 
recommend target areas most in need of vaccinations for selected 
diseases and to determine development of drug resistance. Because of 
the distinct nature of each of the diseases, the number of cases 
reported annually is different for each. There is no cost to 
respondents other than their time. The total burden requested is 11,447 
hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondent                    Form name           respondents    responses per   response  (in
                                                                                    respondent         hrs)
----------------------------------------------------------------------------------------------------------------
Epidemiologist........................  CJD.....................              20               2           20/60
Epidemiologist........................  Cyclosporiasis..........              55              10           15/60
Epidemiologist........................  Dengue..................              55             182           15/60
Epidemiologist........................  Hantavirus..............              46               3           20/60
Epidemiologist........................  Kawasaki Syndrome.......              55               8           15/60
Epidemiologist........................  Legionellosis...........              23              12           20/60

[[Page 15369]]

 
Epidemiologist........................  Lyme Disease............              52             385           10/60
Epidemiologist........................  Malaria.................              55              20           15/60
Epidemiologist........................  Plague..................              11               1           20/60
Epidemiologist........................  Q Fever.................              55               1           10/60
Epidemiologist........................  Reye Syndrome...........              50               1           20/60
Epidemiologist........................  Tick-borne Rickettsia...              55              18           10/60
Epidemiologist........................  Trichinosis.............              25               1           20/60
Epidemiologist........................  Tularemia...............              55               2           20/60
Epidemiologist........................  Typhoid Fever...........              55               6           20/60
Epidemiologist........................  Viral hepatitis.........              55             200           25/60
----------------------------------------------------------------------------------------------------------------


    Dated: February 28, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate 
Director for Science (OADS), Office of the Director, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-05523 Filed 3-8-13; 8:45 am]
BILLING CODE 4163-18-P